134 related articles for article (PubMed ID: 36515452)
1. Anti-ovarian cancer potential, in silico studies, and anti-Alzheimer's disease effects of some natural compounds as cholinesterase inhibitors.
Fu M; Ji C; Yang T; Mao F; Shati AA; El-Kott AF; El-Maksoud MMA; Negm S; Ji Y
Biotechnol Appl Biochem; 2023 Jun; 70(3):1085-1099. PubMed ID: 36515452
[TBL] [Abstract][Full Text] [Related]
2. Bioactivity of hamamelitannin, flavokawain A, and triacetyl resveratrol as natural compounds: Molecular docking study, anticolon cancer, and anti-Alzheimer potentials.
Zhang M; Xue J; Chen X; Elsaid FG; Salem ET; Ghanem RA; El-Kott AF; Xu Z
Biotechnol Appl Biochem; 2023 Apr; 70(2):730-745. PubMed ID: 35933706
[TBL] [Abstract][Full Text] [Related]
3. Potential acetylcholinesterase inhibitors to treat Alzheimer's disease.
Saud A; Krishnaraju V; Taha A; Kalpana K; Malarkodi V; Durgaramani S; Vinoth Prabhu V; Saleh FA; Ezhilarasan S
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2522-2537. PubMed ID: 38567612
[TBL] [Abstract][Full Text] [Related]
4. Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study.
Jamal QMS; Khan MI; Alharbi AH; Ahmad V; Yadav BS
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049419
[TBL] [Abstract][Full Text] [Related]
5. Aaptamine - a dual acetyl - and butyrylcholinesterase inhibitor as potential anti-Alzheimer's disease agent.
Miao S; He Q; Li C; Wu Y; Liu M; Chen Y; Qi S; Gong K
Pharm Biol; 2022 Dec; 60(1):1502-1510. PubMed ID: 35968601
[TBL] [Abstract][Full Text] [Related]
6. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
[TBL] [Abstract][Full Text] [Related]
7. BChE inhibitors from marine organisms - A review.
Lins Alves LK; Cechinel Filho V; de Souza RLR; Furtado-Alle L
Chem Biol Interact; 2022 Nov; 367():110136. PubMed ID: 36096160
[TBL] [Abstract][Full Text] [Related]
8. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
[TBL] [Abstract][Full Text] [Related]
9. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
10. Biphenylalkoxyamine Derivatives-Histamine H
Łażewska D; Zaręba P; Godyń J; Doroz-Płonka A; Frank A; Reiner-Link D; Bajda M; Stary D; Mogilski S; Olejarz-Maciej A; Kaleta M; Stark H; Malawska B; Kieć-Kononowicz K
Molecules; 2021 Jun; 26(12):. PubMed ID: 34208297
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB
ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948
[TBL] [Abstract][Full Text] [Related]
12. Lepidine B from Lepidium sativum Seeds as Multi-Functional Anti- Alzheimer's Disease Agent: In Vitro and In Silico Studies.
Talia S; Benarous K; Lamrani M; Yousfi M
Curr Comput Aided Drug Des; 2021; 17(3):360-377. PubMed ID: 32116197
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate-derived bicyclic selenazolines as new dual inhibitors (cholinesterases/OGA) against Alzheimer's disease.
Velueta-Viveros M; Martínez-Bailén M; Puerta A; Romero-Hernández LL; Křen V; Merino-Montiel P; Montiel-Smith S; Fernandes MX; Moreno-Vargas AJ; Padrón JM; López Ó; Fernández-Bolaños JG
Bioorg Chem; 2022 Oct; 127():105983. PubMed ID: 35779403
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
[TBL] [Abstract][Full Text] [Related]
16. Dual targeting of cholinesterase and amyloid beta with pyridinium/isoquinolium derivatives.
Chakravarty H; Ju Y; Chen WH; Tam KY
Drug Dev Res; 2020 Apr; 81(2):242-255. PubMed ID: 31837041
[TBL] [Abstract][Full Text] [Related]
17. Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches.
Zafar R; Naureen H; Zubair M; Shahid K; Saeed Jan M; Akhtar S; Ahmad H; Waseem W; Haider A; Ali S; Tariq M; Sadiq A
Drug Des Devel Ther; 2021; 15():2679-2694. PubMed ID: 34188447
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholinesterase and butyrylcholinesterase inhibition by nectriapyrone and tryptophol isolated from endophytic fungus
Dos Santos R; Morais-Urano RP; Marçal RM; Silva GH; Santos MFC
Nat Prod Res; 2022 Aug; 36(16):4153-4158. PubMed ID: 34498969
[TBL] [Abstract][Full Text] [Related]
19. Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment.
Adeowo FY; Oyetunji TP; Ejalonibu MA; Ndagi U; Kumalo HM; Lawal MM
Chem Biodivers; 2021 Nov; 18(11):e2100361. PubMed ID: 34547176
[TBL] [Abstract][Full Text] [Related]
20. A Computational Study of Natural Compounds from Bacopa monnieri in the Treatment of Alzheimer's Disease.
Jamal QMS; Siddiqui MU; Alharbi AH; Albejaidi F; Akhtar S; Alzohairy MA; Kamal MA; Kesari KK
Curr Pharm Des; 2020; 26(7):790-800. PubMed ID: 31894743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
